Who is sponsoring NCT05213325?

NCT05213325 is sponsored by Sohag University.

What drugs are being tested in NCT05213325?

Interventions in NCT05213325: Evaluation of serum levels of IL-6 and IL-8.

What condition does NCT05213325 study?

NCT05213325 studies Acute Gastroenteritis, Acute Diarrhea.

Is NCT05213325 still recruiting?

NCT05213325 is currently status unknown. Last updated 28 January 2022.

Last reviewed 2022-01-28 · How we verify

NCT05213325

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Serum Interleukin 6 and 8 in Children With Acute Gastroenteritis

Status unknown Last updated 28 January 2022

What this trial tests

trial testing Evaluation of serum levels of IL-6 and IL-8 in Acute Gastroenteritis in 60 participants. Status unknown.

Timeline

15 December 2021

Primary endpoint
15 December 2022

15 December 2022

Quick facts

Lead sponsor	Sohag University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	60
Start date	15 December 2021
Primary completion	15 December 2022
Estimated completion	15 December 2022
Sites	1 location across Egypt

Drugs / interventions tested

Evaluation of serum levels of IL-6 and IL-8

Conditions studied

Acute Gastroenteritis — all drugs for Acute Gastroenteritis →
Acute Diarrhea — all drugs for Acute Diarrhea →

Sponsor

Sohag University

Who can join

Adults 6 Months to 5, any sex, with Acute Gastroenteritis or Acute Diarrhea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cytokines, such as IL-6 and IL-8 can be used as markers of acute infections, including acute gastroenteritis. This study aims to evaluate serum levels of interleukins 6 and 8 in children with acute gastroenteritis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Acute Gastroenteritis

Currently open trials in the same condition.

NCT06592794 — A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute · Phase 3 · active not recruiting

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05213325 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 28 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05213325.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing